Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-145491
Filing Date
2021-04-30
Accepted
2021-04-30 17:05:01
Documents
7
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d131567ddef14a.htm DEF 14A 587147
2 GRAPHIC g131567g01a10.jpg GRAPHIC 130431
3 GRAPHIC g131567g02k20.jpg GRAPHIC 118877
4 GRAPHIC g131567g03d78.jpg GRAPHIC 48240
5 GRAPHIC g131567g26a01.jpg GRAPHIC 24519
6 GRAPHIC g131567g26b02.jpg GRAPHIC 28873
7 GRAPHIC g131567g26c03.jpg GRAPHIC 23038
  Complete submission text file 0001193125-21-145491.txt   1081111
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38959 | Film No.: 21879429
SIC: 2834 Pharmaceutical Preparations